The application segment of the Single Lumen Microcatheters market is divided into coronary, peripheral vascular, neurovascular, and renal interventions. Coronary procedures dominate due to the high prevalence of coronary artery disease and the demand for precise lesion crossing, accounting for roughly 35% of market revenue. Peripheral vascular applications, encompassing lower‑extremity and iliac artery treatments, contribute about 30%, driven by an aging population and increasing incidence of peripheral artery disease. Neurovascular use, which includes intracranial aneurysm coiling and stroke recanalization, represents approximately 20% of the market, reflecting rapid adoption of endovascular neurosurgery techniques. Finally, renal interventions, primarily for renal artery stenosis, hold a 15% share, supported by growing awareness of renal hypertension management. Together, these application categories define the overall market size and shape strategic investment, with the distribution illustrated in the accompanying pie chart. This breakdown exemplifies the depth of the Single Lumen Microcatheters segmentation.